-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AlSZ4F2BWgbA7FxM0q8HMfuXMkOZ639Hk8/tN7PxprsTq8irpVi2uY93ar0XVhAG ccPAzdR0LDQRpHHkJZaM+A== 0001082045-06-000007.txt : 20060210 0001082045-06-000007.hdr.sgml : 20060210 20060210132532 ACCESSION NUMBER: 0001082045-06-000007 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060210 DATE AS OF CHANGE: 20060210 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ADEZA BIOMEDICAL CORP CENTRAL INDEX KEY: 0000902482 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] IRS NUMBER: 770054952 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-46611 FILM NUMBER: 06596968 BUSINESS ADDRESS: STREET 1: 1240 ELKO DR CITY: SUNNYVALE STATE: CA ZIP: 94089 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WEATHERBIE M A & CO INC/MA CENTRAL INDEX KEY: 0001082045 IRS NUMBER: 020484484 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 265 FRANKLIN STREET STREET 2: SUITE 1601 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 6179512550 MAIL ADDRESS: STREET 1: M A WEATHERBIE & CO INC STREET 2: 265 FRANKLIN ST STE 1601 CITY: BOSTON STATE: MA ZIP: 02110 SC 13G 1 form13g4q2005adza.txt FORM 13 G 1ST FILING ADZA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ___________)* (Name of Issuer) ADEZA BIOMEDICAL CORPORATION (Title of Class of Securities) COMMON STOCK (CUSIP Number) 006864102 (Date of Event Which Requires Filing of this Statement) December 31, 2005 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ X ] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 006864102 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). M.A. Weatherbie & Co., Inc. / 02-0484484 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) 3. SEC Use Only 4. Citizenship or Place of Organization IS A DELAWARE CORPORATION Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 695,192 6. Shared Voting Power 0 7. Sole Dispositive Power 882,034 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person* 882,034 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions 11. Percent of Class Represented by Amount in Row (9) 5.53% 12. Type of Reporting Person (See Instructions) IA Item 1. (a) Name of Issuer ADEZA BIOMEDICAL CORPORATION (b) Address of Issuer's Principal Executive Offices 1240 ELKO DRIVE SUNNYVALE, CA 94089 Item 2. (a) Name of Person Filing M.A. Weatherbie & Co., Inc. is a Delaware Corporation (b) Address of Principal Business Office or, if none, Residence 265 Franklin Street, Suite 1601 Boston, MA 02110 (c) Citizenship M.A. Weatherbie & Co., Inc. is a Delaware Corporation (d) Title of Class of Securities Common Stock (e) CUSIP Number 006864102 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (e) [ X ] M.A. Weatherbie & Co., Inc., is an investment adviser registered under section 203 of the Investment Advisers Act of 1940 Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item (a) Amount beneficially owned: M.A. Weatherbie & Co., Inc. Managed accounts 882,034 (b) Percent of class: 5.53% Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. Not applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of Group Not applicable. Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 10, 2006 Date By: /S/ MATTHEW A. WEATHERBIE Signature Matthew A. Weatherbie, President United States Securities and Exchange Commission Schedule 13G (cover page) ADEZA BIOMEDICAL CORPORATION (Issuer) Box 9. The reported shares are owned by several accounts managed, with discretion to purchase or sell securities, by M.A. Weatherbie & Co., Inc., a registered investment adviser. M.A. Weatherbie & Co., Inc., disclaims beneficial ownership of the shares reported. UNDERTAKING The undersigned agrees to file the attached Statement of Beneficial Ownership on Schedule 13G/A with the U.S. Securities Exchange Commission and ADEZA BIOMEDICAL CORPORATION Dated: February 10, 2006 M.A. WEATHERBIE & CO., INC. By: /S/ MATTHEW A. WEATHERBIE Matthew A. Weatherbie, President -----END PRIVACY-ENHANCED MESSAGE-----